Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sensilab is a leading European healthcare company specializing in the development and commercialization of high-quality dietary supplements and natural health solutions. Founded in 2005 and headquartered in Slovenia, the company offers an extensive portfolio of products focused on weight management, detoxification, and hormonal balance under brands such as SlimJOY and TummyTox. Sensilab operates its own state-of-the-art R&D and manufacturing facilities in Poland, ensuring that all products meet rigorous pharmaceutical-grade quality standards, including GMP and ISO certifications. The company has established a strong international presence, distributing its products to over 40 countries and serving millions of customers across Europe. In 2021, Sensilab was acquired by Vision Healthcare, a major European consumer healthcare platform, further accelerating its growth and digital expansion. The company continues to innovate by combining traditional herbal medicine with modern nutritional science to address common health concerns like metabolic health and immune support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sensilab.